Lankenau Institute for Medical Research

Wynnewood, Pennsylvania 19096-3450

5 studies enrolling now · 29 studies all time

What they study most

Acute Coronary Syndrome, Anastomotic Complication, Anastomotic Leak, Anastomotic Leaks, Aorta; Lesion, Aortic Aneurysm, Thoracic, Aortic Dissection, Aortic Valve Disease, Aortic Valve Stenosis, Arrhythmia, Atrial Fibrillation, Atrial Flutter

Studies at this site

• ELEVATE-HFpEF Clinical Study — Recruiting now
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections — Recruiting now
• The THOR IDE Study — Recruiting now
• CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting — Recruiting now
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Evaluation of the GORE® Ascending Stent Graft — Enrolling by invitation
• MitraClip REPAIR MR Study — Running, not enrolling
• ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation — Enrolling by invitation
• CLIP-IT Post-Market Study — Running, not enrolling
• To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) — Completed
• Early Feasibility Study - Edwards APTURE Transcatheter Shunt System — Running, not enrolling
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System — Completed
• AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
• Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification (SITRAL) Study — Completed
• PerQseal® Clinical Study — Running, not enrolling
• Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) — Completed
• Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin — Completed
• Empiric Quinidine for Asymptomatic Brugada Syndrome — Withdrawn before enrolling
• Natural Vascular Scaffold (NVS) Therapy — Completed
• Ranolazine Implantable Cardioverter-Defibrillator Trial — Completed
• REVEAL AF: Incidence of AF in High Risk Patients — Completed
• Micra Transcatheter Pacing System Continued Access Study Protocol — Completed
• Micra Transcatheter Pacing Study — Completed
• ATS 3f(r) Aortic Bioprosthesis Model 1000, 19mm — Stopped early
• CARTO® 3 System and Real Time Intracardiac Ultrasound — Completed
• Effect of Zinc on Barrett's Metaplasia — Status unconfirmed
• Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation — Status unconfirmed